CN109575095A - A kind of preparation method of 16a- hydroxacetic acid prednisolone - Google Patents
A kind of preparation method of 16a- hydroxacetic acid prednisolone Download PDFInfo
- Publication number
- CN109575095A CN109575095A CN201910050760.6A CN201910050760A CN109575095A CN 109575095 A CN109575095 A CN 109575095A CN 201910050760 A CN201910050760 A CN 201910050760A CN 109575095 A CN109575095 A CN 109575095A
- Authority
- CN
- China
- Prior art keywords
- acid
- organic solvent
- protection
- added
- hydroxacetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002253 acid Substances 0.000 title claims abstract description 91
- 229960005205 prednisolone Drugs 0.000 title claims abstract description 46
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000003960 organic solvent Substances 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 230000007062 hydrolysis Effects 0.000 claims abstract description 31
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 31
- 238000006722 reduction reaction Methods 0.000 claims abstract description 15
- 238000000746 purification Methods 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 12
- 239000012286 potassium permanganate Substances 0.000 claims abstract description 12
- MOVRKLZUVNCBIP-RFZYENFJSA-N cortancyl Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O MOVRKLZUVNCBIP-RFZYENFJSA-N 0.000 claims abstract description 10
- 238000007171 acid catalysis Methods 0.000 claims abstract description 9
- 239000011260 aqueous acid Substances 0.000 claims abstract description 6
- 150000002576 ketones Chemical class 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 33
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 229960004618 prednisone Drugs 0.000 claims description 26
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims description 25
- 239000000376 reactant Substances 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- 239000012043 crude product Substances 0.000 claims description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000003377 acid catalyst Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 21
- 239000012065 filter cake Substances 0.000 claims description 20
- 238000005406 washing Methods 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 17
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 16
- 238000004064 recycling Methods 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 230000001590 oxidative effect Effects 0.000 claims description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000010808 liquid waste Substances 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 239000007800 oxidant agent Substances 0.000 claims description 10
- 229960000583 acetic acid Drugs 0.000 claims description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000007858 starting material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000007805 chemical reaction reactant Substances 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- 125000003944 tolyl group Chemical group 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229940013688 formic acid Drugs 0.000 claims description 2
- -1 is stirred Substances 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 238000005292 vacuum distillation Methods 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims 1
- 229940092714 benzenesulfonic acid Drugs 0.000 claims 1
- 239000002351 wastewater Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 238000007254 oxidation reaction Methods 0.000 abstract description 14
- 239000012535 impurity Substances 0.000 abstract description 10
- 230000003647 oxidation Effects 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000011084 recovery Methods 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 238000010511 deprotection reaction Methods 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 238000007086 side reaction Methods 0.000 abstract description 3
- 238000007039 two-step reaction Methods 0.000 abstract description 2
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000004148 unit process Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 26
- 239000002585 base Substances 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical group [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960004436 budesonide Drugs 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- WRLRISOTNFYPMU-UHFFFAOYSA-N [S].CC1=CC=CC=C1 Chemical compound [S].CC1=CC=CC=C1 WRLRISOTNFYPMU-UHFFFAOYSA-N 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- WBGKWQHBNHJJPZ-LECWWXJVSA-N desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 description 2
- 229960003662 desonide Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- LRJOMUJRLNCICJ-JZYPGELDSA-N Prednisolone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O LRJOMUJRLNCICJ-JZYPGELDSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940073541 econopred Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
A kind of preparation method of 16a- hydroxacetic acid prednisolone, is dissolution of raw material in organic solvent using 17- deshydroxy prednisone acetate, with potassium permanganate oxidation 16 under acid catalysis; 17 double bonds; oxide is made, then gained oxide is dissolved in acetone, acid catalyzed reaction obtains protection；Then protection obtained above is dissolved in organic solvent, reducing agent is added and restores 11 ketone, and is directly added into aqueous acid after reduction reaction, 16a- hydroxacetic acid prednisolone is made in hydrolysis deprotection.Although the present invention increases protection, deprotection two-step reaction; but each step unit process high income; 3rd, step 4 reaction can treat different things alike; production operation is simple and convenient, and production technology is economic and environment-friendly, and it is more to substantially reduce oxidation reaction side reaction in traditional processing technology; impurity is more; and the problem of impurity difficulty purification, synthesis total recovery greatly improved, preparation cost of the invention reduces by 20~25% than conventional production methods.
Description
Technical field
The invention belongs to the fabricating technologies of steroid hormone pharmaceutical intermediate, and in particular to one kind with 17- deshydroxy vinegar
Sour prednisone is raw material, is reacted through 3 steps to synthesize the key intermediate 16a- hydroxyl of cortex hormone of aadrenaline drug budesonide
The fabricating technology of Econopred.
Background technique
16a- hydroxacetic acid prednisolone (molecular formula C23H28O7), chemistry entitled 11b, 16a, 17a, 21- tetrahydroxy-pregnant
Steroid-Isosorbide-5-Nitrae-diene -3,20- diketone, 21 acetates are the key that a kind of production how in moral class steroidal cortex hormone of aadrenaline drug
Mesosome, as soon as acetic acid desonide is just made with the condensation reaction of acetone step, is condensed with one step of n-butanal and acetic acid is made using it as raw material
Desonide and budesonide is just made in budesonide respectively after hydrolysis, how moral class steroidal cortex hormone of aadrenaline drug is one
The potent local anti-inflammatory agent of class, such as budesonide are clinically mainly used for many diseases of various rhinitis, acute/chronic bronchitis
Treatment, side effect is low, and effect is good, wide market.16a- hydroxacetic acid prednisolone can be also used for preparation 16a- hydroxyl
Base prednisolone, 16a- hydroxy prednisonlone are also a kind of key intermediate for preparing budesonide.16a- hydroxy prednisonlone
Conventional production methods, be using prednisolone as raw material, eliminated through 17,21 double esterifications, 17-position ester, the oxidation of 16,17 double bonds,
The four-step reactions such as 21 ester hydrolysis are made, and wherein 16a- hydroxacetic acid prednisolone is prepared in first three step, and specific steps are shown in
16a- hydroxy prednisonlone is prepared by 16a- hydroxacetic acid prednisolone in Fig. 1, the 4th step.The method synthesizes 16a- hydroxyl and sprinkles Buddhist nun
Song Long, synthesis total recovery is low, the main reason is that: when being on the one hand with 16,17 double bonds of potassium permanganate oxidation, due to Gao Meng
The strong oxidizing property of sour potassium, will lead to 11 hydroxyls in molecule can also be oxidized, the product 16a- hydroxacetic acid prednisone generated
16 hydroxyls in imperial molecule can be also oxidized, and cause impurity more, hardly possible purifying, so that it is low to aoxidize this step yield；On the other hand it is
4th step 16a- hydroxacetic acid prednisolone is with such as sodium hydroxide or sodium carbonate highly basic or such as hydrochloric acid, sulfuric acid strong acid hydrolysis
When, open loop rearrangement ring-enlarging reaction can be generated by D ring in the molecule, generate two very big impurity, the two impurity are also difficult to remove,
The yield for causing the 4th one-step hydrolysis to react is also very low.Therefore, 16a- hydroxy prednisonlone is produced with the method, the production cost is very high,
Cause budesonide class pharmaceutical market price very high, considerably increases drug cost when such Case treatment.
The patent CN201710765122.3 of the applicant's earlier application provides a kind of preparation of 16a- hydroxy prednisonlone
Method is to dissolve in 16a- hydroxacetic acid prednisolone in organic solvent, and the inert solid carrier conduct for having adsorbed highly basic is added
16a- hydroxy prednisonlone crude product is made in 21 acetic acid ester hydrolysis by hydrolysis solid base catalyst；Crude product is low through C4 or less
Carbon alcohol recrystallization, obtains 16a- hydroxy prednisonlone fine work.Above-mentioned solid carrier is selected from aluminium oxide or silica gel or calcium carbonate；Base catalysis
Sodium carbonate is selected in agent；Organic solvent is selected from toluene or chloroform etc..This method is compared with the traditional method, and production operation is simple and convenient,
The impurity generated in traditional mode of production can be greatly reduced, synthesis total recovery is greatly improved.
That is, above-mentioned prepared the defect of 16a- hydroxy prednisonlone step by 16a- hydroxacetic acid prednisolone
It is greatly improved, but final step in above-mentioned Fig. 1 (i.e. above-mentioned third step reaction) is by 16- alkene -17- deshydroxy-prednisone acetate
Dragon aoxidized under potassium permanganate generate 16a- hydroxacetic acid prednisolone the step of do not improved.Such as patent
CN201410455522 is also the side using 16,17 double bonds with potassium permanganate oxidation prednisolone structure similar in Fig. 1
Method produces 16a hydroxy prednisonlone, this also results in 11 hydroxyls and is oxidized.
Therefore, this field needs the preparation side of a kind of new 16a- hydroxacetic acid prednisolone and 16a- hydroxy prednisonlone
Method.
Patent CN201010106918.6 is related to a kind of synthetic method of 16 alpha-hydroxy prednisonlones.The invention uses strong
Pine is starting material, is made by elimination, oxidation, condensation, reduction and hydrolysis five steps reaction.The intermediate compound I of the patent and centre
Body II is respectively 17- deshydroxy prednisone acetate and its oxide 16a- hydroxacetic acid prednisone, and 16a- hydroxacetic acid sprinkles Buddhist nun thereafter
16 alpha-hydroxy prednisonlones are prepared by condensation, reduction and hydrolysis in pine, but wherein need using condensing agent hydrochloric acid amido urea
It is hydrolyzed with nitrite aqueous solution.The program still has that environmental protection pressure is big and what yield was not high thus at high cost lacks
It falls into.Therefore, Buddhist nun is sprinkled there is still a need for new synthesis 16a- hydroxy prednisonlone and its intermediate 16a- hydroxacetic acid is developed in this field
The preparation method of Song Long.
Summary of the invention
Therefore, the present invention is for oxygen in tradition 16a- hydroxy prednisonlone and 16a- hydroxacetic acid prednisolone production technology
Change reaction side reaction it is more, the low problem of the more yields of impurity, for high-efficiency environment friendly be prepared 16a- hydroxy prednisonlone and
16a- hydroxacetic acid prednisolone using first first preparing 16a- hydroxacetic acid prednisolone with ad hoc approach in the present invention, then leads to
The method for crossing the basic hydrolysis under given conditions of 16a- hydroxacetic acid prednisolone obtains 16a- hydroxy prednisonlone.
The present invention provides a kind of preparation method of 16a- hydroxacetic acid prednisolone, which comprises
It first using 17- deshydroxy prednisone acetate as raw material, is dissolved in the first organic solvent, with oxidation under acid catalysis
Agent aoxidizes 16,17 double bonds, and oxide: 16a- hydroxacetic acid prednisone is made；
Above-mentioned obtained 16a- hydroxacetic acid prednisone is dissolved in the second organic solvent again, acetone is added, acid is urged
Change and reacts to obtain the protection protected by acetone of 16,17 hydroxyls；
Then protection obtained above is dissolved in third organic solvent, it is hydroxyl that reducing agent, which is added, and restores 11 ketone
Base, and aqueous acid is directly added into as acid catalyst after reduction reaction, the acetone protection of 16,17 hydroxyls is taken off in hydrolysis,
16a- hydroxacetic acid prednisolone is made.
In a specific embodiment, which comprises
A, the preparation of oxide:
It is that 17- deshydroxy prednisone acetate is dissolved in the first organic solvent, acid catalyst, stirring, temperature control to 10 is added
It~50 DEG C, in oxidant potassium permanganate aqueous solution is added dropwise in 1~1.5 hour, after dripping off, then reacts 1~2 hour, TLC control is anti-
Terminal is answered, after having reacted, vacuum distillation recovered solvent, residue is cooled to room temperature, and pure water elutriation is added, and oxidation is made in filtering
Object: 16a- hydroxacetic acid prednisone crude product；The crude product is recrystallized with alcohol water blend, obtains 16a- hydroxacetic acid prednisone；
B, the preparation of protection:
Above-mentioned oxide is dissolved in the second organic solvent, is stirred, acetone and acid catalyst is added, keep the temperature lower reaction 6~
12 hours, TLC confirmed reaction end, after having reacted, suitable alkali neutralization acid was added, then having for recycling 90~95% is concentrated under reduced pressure
Then solvent is cooled to room temperature, pure water elutriation, filtering is added, and filtrate is discharged into purification tank for liquid waste, and filter cake washing and drying must be protected
Protect object；
C, the preparation of 16a- hydroxacetic acid prednisolone:
Protection prepared by above-mentioned B is dissolved in third organic solvent, is stirred, under heat preservation slowly in 1~1.5 hour
Reducing agent is added, the reaction was continued 3~4 hours after adding, and TLC confirms reaction end, slow in 0.5~1.0 hour after having reacted
The aqueous acid of slow dropwise addition 5~10% after adding, continues hydrolysis 3~4 hours, and TLC confirms hydrolysis terminal, reaction
After complete, the organic solvent of recycling 90~95% is concentrated under reduced pressure, is then cooled to room temperature, pure water elutriation, filtering is added, filtrate is discharged into
Purification tank for liquid waste, filter cake washing and drying obtain 16a- hydroxacetic acid prednisolone.
In a specific embodiment, in the A oxide prepare first organic solvent be acetone, toluene,
One or both of chloroform, ethyl acetate, THF, DME；Oxidant potassium permanganate concentration is 1~10%；Acid catalyst is salt
One of acid, sulfuric acid, phosphoric acid, p-methyl benzenesulfonic acid, acetic acid and formic acid；Weight proportion between reactant is starting material: oxidation
Agent: acid catalyst=1g:0.2~0.8g:0.05~0.25g, the proportion between reactant and solvent are starting materials: first has
Solvent=1g:10~30ml.
In a specific embodiment, first organic solvent for preparing of oxide is acetone in the A；Oxidant
Concentration is 3~5%；Acid catalyst is formic acid；Oxidizing reaction temperature is 20~25 DEG C；Weight proportion between reactant is to originate
Raw material: oxidant: acid catalyst=1g:0.45g:0.1g, the proportion between reactant and solvent are starting materials: first is organic
Solvent=1g:20ml.
In a specific embodiment, in the B protection prepare second organic solvent be acetone, toluene,
One or both of chloroform, ethyl acetate, THF, DME；Acid catalyst is hydrochloric acid, sulfuric acid, phosphoric acid, p-methyl benzenesulfonic acid, acetic acid
Or one of formic acid；Protecting reaction temperature is 10~60 DEG C；Weight proportion between reactant is oxide: acetone: acid catalysis
Agent=1g:0.4~1.2g:0.01~0.20g, the proportion between reactant and solvent are oxides: the second organic solvent=1g:2
~10ml.
In a specific embodiment, second organic solvent for preparing of protection is acetone in the B；Acid catalysis
Agent is p-methyl benzenesulfonic acid；Protecting reaction temperature is 25~30 DEG C；Weight proportion between reactant is oxide: acetone: acid catalysis
Agent=1g:0.6g:0.05g, the proportion between reactant and solvent are oxides: the second organic solvent=1g:5ml.
In a specific embodiment, third described in the preparation of 16a- hydroxacetic acid prednisolone is organic molten in the C
Agent is toluene, methylene chloride, acetone, chloroform, THF, DME, dioxane or C4 and following low-carbon alcohols；Reducing agent is hydroboration
One of sodium, potassium borohydride, Lithium Aluminium Hydride；Reduction reaction temperature is 10~60 DEG C；Acid in the sour water of hydrolysis is salt
One of acid, sulfuric acid, phosphoric acid, p-methyl benzenesulfonic acid, acid or glacial acetic acid；Hydrolysising reacting temperature is 10~60 DEG C；Reduction reaction is anti-
Answering the weight proportion between object is protection: reducing agent=1g:0.06~0.20g；Weight proportion between hydrolysis reactant
It is protection: acid catalyst=1g:0.20~0.40g；Proportion between reactant and solvent is protection: third organic solvent
=1g:5~15ml.
In a specific embodiment, third described in the preparation of 16a- hydroxacetic acid prednisolone is organic molten in the C
Agent is alcohol；Reducing agent is sodium borohydride or potassium borohydride；Reduction reaction temperature is 20~25 DEG C；The acid of hydrolysis is salt
Acid；Hydrolysising reacting temperature is 40~45 DEG C；Weight proportion between reduction reaction reactant is protection: reducing agent=1g:
0.08g；Weight proportion between hydrolysis reactant is protection: acid=1g:0.28g；Proportion between reactant and solvent
It is protection: third organic solvent=1g:10ml.
The beneficial effect comprise that
The present invention uses 17- deshydroxy prednisone acetate for raw material, is first dissolved in the first organic solvent, in acid catalysis
It is lower to obtain 16,17 pairs of hydroxyl objects with 16,17 double bonds of potassium permanganate oxidation；Again in a second organic solvent by above-mentioned 16,17 pairs of hydroxyl objects,
Double hydroxyls are protected under acid catalysis with acetone；Then 11 ketone are restored with reducing agent in third organic solvent again, and directly added
The deprotection of sour water solution, three steps, which operate, is made 16a- hydroxacetic acid prednisolone；The 16a- hydroxyl vinegar produced using the method for the present invention
Sour prednisolone, then in the 4th organic solvent, 16a- hydroxy prednisonlone is produced with solid phase alkali catalyzed hydrolysis method.This hair
Although increasing protection, deprotection two-step reaction in the bright production technology for preparing 16a- hydroxy prednisonlone, each step unit is anti-
High income is answered, reduction and deprotection reaction can treat different things alike, and production operation is simple and convenient, and production technology is economic and environment-friendly, and significantly
Reduce in 16a- hydroxacetic acid prednisolone traditional processing technology that oxidation reaction side reaction is more, impurity is more, and impurity difficulty refines
The problem of, the total recovery of synthesis 16a- hydroxy prednisonlone, the side with traditional mode of production 16a- hydroxy prednisonlone greatly improved
Method is compared, and the preparation cost of the method for the present invention will reduce by 20~25%.In addition, solvent used in this law production, recyclable to follow
Ring set is used, easily implementation industrialized production.
In conclusion the present invention is few with a kind of intermediate product impurity, and the method for efficient, environmental protection and par is prepared
16a- hydroxy prednisonlone and its intermediate 16a- hydroxacetic acid prednisolone.
Detailed description of the invention
Fig. 1 is the synthetic route chart of tradition 16a- hydroxacetic acid prednisolone.
Fig. 2 is the synthetic route chart that 16a- hydroxacetic acid prednisolone is produced in the present invention.
Specific embodiment
In order to which main points and spirit of the invention are described in more detail, name several embodiments and be explained.
Embodiment 1
A, the preparation of oxide:
In a 5000ml there-necked flask, addition 100g17- deshydroxy prednisone acetate, 2000ml acetone, 12.5g80%'s
Formic acid, stirring are completely dissolved solid, and temperature control is to 20~25 DEG C, in the potassium permanganate water that 900g5% is added dropwise in 1~1.5 hour
Solution after dripping off, reacts 1~2 hour again at 20~25 DEG C, and TLC controls reaction end, after having reacted, 35 DEG C or less decompressions
The solvent acetone set for being distilled to recover 90~95% is used for lower batch of oxidation reaction, and residue is cooled to room temperature, and 1000ml pure water is added
Oxide: 16a- hydroxacetic acid prednisone crude product is made in elutriation, filtering；The alcohol water blend weight of crude product 1000ml50%
Crystallization, obtains 16a- hydroxacetic acid prednisone 93.8g, HPLC content 97.5%, weight yield about 93.8%；
B, the preparation of protection:
In a 1000ml there-necked flask, oxide prepared by the above-mentioned A of 100g is added, 500ml acetone, 5g is to toluene sulphur
Acid, stirring are completely dissolved solid, and heat preservation is reacted 8~12 hours in 25~30 DEG C, and TLC confirms reaction end, after having reacted, add
Enter 5ml triethylamine neutralizing acid, then the solvent acetone of recycling 90~95% is concentrated under reduced pressure, be then cooled to room temperature, it is pure that 500ml is added
Water elutriation, filtering, filtrate are discharged into purification tank for liquid waste, and filter cake is washed to neutrality, and 70 DEG C or less dryings obtain protection 16,17- acetone
Contracting -16a- hydroxacetic acid prednisone 109.2g, HPLC content 97.5%, weight yield 109.2%；
C, the preparation of 16a- hydroxacetic acid prednisolone:
In a 2000ml there-necked flask, protection prepared by the above-mentioned B of 100g, 1000ml alcohol is added, stirring makes solid
Body is completely dissolved, and keeps the temperature in 20~25 DEG C, 8g sodium borohydride is slowly added in about 1~1.5 hour, and it is anti-to add subsequent continuation of insurance temperature
It answers 3~4 hours, TLC confirms reaction end, and after having reacted, the hydrochloric acid water of 280g10% is slowly added dropwise in 0.5~1.0 hour
Solution, after adding, continue 40~45 DEG C hydrolysis 3~4 hours, TLC confirm hydrolysis terminal, after having reacted, 60 DEG C
The alcohol set that recycling 90~95% is concentrated under reduced pressure below is reacted for this step, and residue is cooled to room temperature, and 500ml pure water water is added
Analysis, filtering, filtrate are discharged into purification tank for liquid waste, and filter cake washing and drying obtains 16a- hydroxacetic acid prednisone crude product 95g, by the 16a-
Prednisone acetate crude product is dissolved in 500ml50% alcohol, and 5g active carbon is added, and reflux decoloration 1~1.5 hour is filtered while hot,
100ml alcohol washes charcoal, and filter cake send producer to recycle, and filtrate and washing lotion merging are concentrated into extraction raffinate body about 120~150ml, is cooled to -5
~0 DEG C crystallizes 4~5 hours, and filtering, disposing mother liquor is applied, and 70 DEG C of filter cake or less drying obtain 16a- hydroxacetic acid prednisone
89.6g, HPLC content 98.5%, weight yield 89.6%.
D, the preparation of 16a- hydroxy prednisonlone
In a 2000ml there-necked flask, it is raw material that the 16a- hydroxacetic acid prednisolone prepared in 100g step C, which is added,
1500ml toluene makes it completely dissolved under stirring, adds the solid base catalyst that 30g makes by oneself, keeps the temperature in 40~45 DEG C
Stirring hydrolysis 6-8 hours, TLC confirm reaction end, and after having reacted, nitrogen filters pressing while hot, filter cake is divided to two with 500ml toluene
Then secondary foam washing recycles solid base catalyst and applies；Filtrate merges with washing lotion, and 95% toluene of recycling is concentrated under reduced pressure, then cools down,
Pure water elutriation is added, centrifugation, remaining toluene is first recovered under reduced pressure in filtrate, then is discharged into purification tank for liquid waste, and filter cake washing and drying obtains
16a- hydroxy prednisonlone crude product 88.2g, HPLC content 98.8%, weight yield 88.2%；By above-mentioned 16a- hydroxyl prednisone
Imperial crude product dissolves in 800ml alcohol, be added 5g active carbon, be then heated to reflux 1.0-1.5 hours, filters pressing while hot, filter cake with
Foam washing Hou Song producer recycles 100ml alcohol in two times, and 95% alcohol of recycling is concentrated under reduced pressure after filtrate and washing lotion merging, be cooled to-
5-0 DEG C, stirred crystallization 2-3 hours, filtering, filter cake was rinsed with the cold alcohol of 5ml, and drying obtains 16a- hydroxy prednisonlone fine work
78.9g, HPLC content 99.4% refines weight yield 89.5%, prepares weight total recovery 78.9%；Filtrate recovered alcohol and mother
Liquid material set is used for lower batch of process for refining.
In addition, preparing solid base catalyst in the present embodiment step D, detailed process is as follows: in a 1000ml there-necked flask
In, the solution being made by 50g solid alumina, 300ml pure water, 200ml pure water and 15g sodium carbonate is added, is stirred in 25-30 DEG C
Adsorption reaction 3~4 hours, after having reacted, decompression boiled off water and does to close, took out dry that solid base catalyst 50.1g, moisture contain
Amount 5.6%, weight yield 102%.
Embodiment 2
A, the preparation of oxide:
In a 5000ml there-necked flask, 100g17- deshydroxy prednisone acetate, 1500ml chloroform, the phosphorus of 15g20% is added
Acid, stirring are completely dissolved solid, and temperature control is water-soluble in the potassium permanganate that 1500g3% is added dropwise in 1~1.5 hour to 20~25 DEG C
Liquid after dripping off, reacts 1~2 hour again at 20~25 DEG C, and TLC controls reaction end, and after having reacted, 35 DEG C or less decompressions are steamed
The solvent chloroform set of recycling 90~95% is evaporated for lower batch of oxidation reaction, and residue is cooled to room temperature, and 1000ml pure water water is added
Oxide: 16a- hydroxacetic acid prednisone crude product is made in analysis, filtering；The crude product is tied again with the alcohol water blend of 1000ml50%
Crystalline substance obtains 16a- hydroxacetic acid prednisone 91.6g, HPLC content 98.0%, weight yield about 91.6%；
B, the preparation of protection:
In a 1000ml there-necked flask, oxide prepared by the addition above-mentioned A of 100g, 50ml acetone, 500ml chloroform,
5g p-methyl benzenesulfonic acid, stirring are completely dissolved solid, and heat preservation is reacted 8~12 hours in 25~30 DEG C, and TLC confirms reaction end,
After having reacted, 5ml triethylamine neutralizing acid is added, then the solvent chloroform of recycling 90~95% is concentrated under reduced pressure, is then cooled to room temperature,
500ml pure water elutriation, filtering is added, filtrate is discharged into purification tank for liquid waste, and filter cake is washed to neutrality, and 70 DEG C or less dryings must be protected
Object 16,17- acetone contracting -16a- hydroxacetic acid prednisone 105.2g, HPLC content 97.8%, weight yield 105.2%；
C, the preparation of 16a- hydroxacetic acid prednisolone:
In a 2000ml there-necked flask, protection prepared by the above-mentioned B of 100g, 1000ml methanol is added, stirring makes solid
Body is completely dissolved, and keeps the temperature in 20~25 DEG C, 8g potassium borohydride is slowly added in about 1~1.5 hour, and it is anti-to add subsequent continuation of insurance temperature
It answers 3~4 hours, TLC confirms reaction end, and after having reacted, the sulfuric acid water of 280g10% is slowly added dropwise in 0.5~1.0 hour
Solution, after adding, continue 40~45 DEG C hydrolysis 3~4 hours, TLC confirm hydrolysis terminal, after having reacted, 40 DEG C
The methanol set that recycling 90~95% is concentrated under reduced pressure below is reacted for this step, and residue is cooled to room temperature, and 500ml pure water water is added
Analysis, filtering, filtrate are discharged into purification tank for liquid waste, and filter cake washing and drying obtains 16a- hydroxacetic acid prednisone crude product 95g, by the 16a-
Prednisone acetate crude product obtains 16a- hydroxacetic acid prednisone 86.8g, HPLC contains by the recrystallization of method described in the embodiment 1C
Amount 98.7%, weight yield 86.8%.
D, the preparation of 16a- hydroxy prednisonlone:
In a 2000ml there-necked flask, it is raw material that the 16a- hydroxacetic acid prednisolone prepared in 100g step C, which is added,
1500ml alcohol makes it completely dissolved under stirring, adds the solid base catalyst that 30g makes by oneself, keeps the temperature in 40~45 DEG C
Stirring hydrolysis 6-8 hours, TLC confirm reaction end, and after having reacted, nitrogen filters pressing while hot, filter cake is divided to two with 500ml alcohol
Then secondary foam washing recycles solid base catalyst and applies；Filtrate merges with washing lotion, and 95% alcohol of recycling is concentrated under reduced pressure, then cools down,
Pure water elutriation is added, centrifugation, remaining alcohol is first recovered under reduced pressure in filtrate, then is discharged into purification tank for liquid waste, and filter cake washing and drying obtains
16a- hydroxy prednisonlone crude product 87.8g, HPLC content 98.6%, weight yield 87.8%；16a- hydroxy prednisonlone is thick
Product are recrystallized according to step C the method in embodiment 1, obtain 16a- hydroxy prednisonlone fine work 77.6g, HPLC content
99.5%, weight yield 88.4% is refined, weight total recovery 77.6% is prepared；Filtrate recovered alcohol and mother liquor material set are used for lower batch
In process for refining.
In addition, preparing solid base catalyst in the present embodiment step D, detailed process is as follows: in accordance with the above-mentioned embodiment 1
Aluminium oxide, is only changed into silica gel by the preparation method of solid base catalyst described in step D, and the solid phase alkali for making carrier with silica gel is made
Catalyst 49.8g, water content 6.8%.
Embodiment 3
A, the preparation of oxide:
In a 5000ml there-necked flask, 100g17- deshydroxy prednisone acetate, the vinegar of 1500mlDME, 50g20% is added
Acid, stirring are completely dissolved solid, and temperature control is water-soluble in the potassium permanganate that 900g5% is added dropwise in 1~1.5 hour to 20~25 DEG C
Liquid after dripping off, reacts 1~2 hour again at 20~25 DEG C, and TLC controls reaction end, and after having reacted, 35 DEG C or less decompressions are steamed
The solvent DME set of recycling 90~95% is evaporated for lower batch of oxidation reaction, and residue is cooled to room temperature, and 1000ml pure water water is added
Oxide: 16a- hydroxacetic acid prednisone crude product is made in analysis, filtering；The crude product is tied again with the alcohol water blend of 1000ml50%
Crystalline substance obtains 16a- hydroxacetic acid prednisone 92.5g, HPLC content 97.6%, weight yield about 92.5%；
B, the preparation of protection:
In a 1000ml there-necked flask, oxide prepared by the above-mentioned A of 100g, 50ml acetone, 500mlTHF, 5g is added
Sulfuric acid, stirring are completely dissolved solid, and heat preservation is reacted 8~12 hours in 25~30 DEG C, and TLC confirms reaction end, after having reacted,
5ml triethylamine neutralizing acid is added, then the solvent THF of recycling 90~95% is concentrated under reduced pressure, is then cooled to room temperature, 500ml is added
Pure water elutriation, filtering, filtrate are discharged into purification tank for liquid waste, and filter cake is washed to neutrality, and 70 DEG C or less dryings obtain protection 16,17- third
Ketone contracting -16a- hydroxacetic acid prednisone 106.7g, HPLC content 97.6%, weight yield 106.7%；
C, the preparation of 16a- hydroxacetic acid prednisolone:
In a 2000ml there-necked flask, protection prepared by the above-mentioned B of 100g, 1000mlDME is added, stirring makes solid
It is completely dissolved, keeps the temperature in 20~25 DEG C, 6g Lithium Aluminium Hydride is slowly added in about 1~1.5 hour, adds subsequent continuous insulation reaction
3~4 hours, TLC confirm reaction end, after having reacted, be slowly added dropwise in 0.5~1.0 hour 350g10% to toluene sulphur
Aqueous acid, after adding, continue 40~45 DEG C hydrolysis 3~4 hours, TLC confirm hydrolysis terminal, after having reacted,
40 DEG C or less the DME sets that recycling 90~95% is concentrated under reduced pressure are reacted for this step, and residue is cooled to room temperature, and it is pure that 500ml is added
Water elutriation, filtering, filtrate are discharged into purification tank for liquid waste, and filter cake washing and drying obtains 16a- hydroxacetic acid prednisolone crude product 96g, will
The 16a- hydroxacetic acid prednisolone crude product obtains 16a- hydroxacetic acid prednisone by the recrystallization of method described in the embodiment 1C
Imperial 86.2g, HPLC content 98.4%, weight yield 86.2%.
D, the preparation of 16a- hydroxy prednisonlone:
In a 2000ml there-necked flask, it is raw material that the 16a- hydroxacetic acid prednisolone prepared in 100g step C, which is added,
1500ml chloroform makes it completely dissolved under stirring, adds the alkaline carbonic acid calcium solid base catalyst that 30g makes by oneself, heat preservation
In 40~45 DEG C stirring hydrolysis 6-8 hours, TLC confirm reaction end, after react, nitrogen filters pressing while hot, filter cake use
Then 500ml chloroform foam washing in two times recycles solid base catalyst and applies；Filtrate merges with washing lotion, and recycling 95% is concentrated under reduced pressure
Then chloroform cools down, tap water elutriation is added, and centrifugation, remaining chloroform is first recovered under reduced pressure in filtrate, then is discharged into purification tank for liquid waste,
Filter cake washing and drying obtains 16a- hydroxy prednisonlone crude product 88.2g, HPLC content 98.9%, weight yield 88.2%；It will be above-mentioned
16a- hydroxy prednisonlone crude product is recrystallized by 1 step D the method for embodiment, obtains 16a- hydroxy prednisonlone fine work
78.2g, HPLC content 99.3% refines weight yield 88.7%, prepares weight total recovery 78.2%；Filtrate recovered alcohol and mother
Liquid material set is in lower batch of process for refining.
In addition, preparing solid base catalyst in the present embodiment step D, detailed process is as follows: in accordance with the above-mentioned embodiment 1
Aluminium oxide is only changed into calcium carbonate by the preparation method of solid base catalyst described in step D, and sodium carbonate changes sodium hydroxide into, system
It is able to the solid base catalyst 49.6g that calcium carbonate makees carrier, water content 4.8%.
The above content is combine specific preferred embodiment to the further description of the invention made, and it cannot be said that originally
The specific implementation of invention is only limited to these instructions.For those of ordinary skill in the art to which the present invention belongs, not
Under the premise of being detached from present inventive concept, several simple deductions and replacement can also be made, all shall be regarded as belonging to guarantor of the invention
Protect range.
Claims (8)
1. a kind of preparation method of 16a- hydroxacetic acid prednisolone, which is characterized in that the described method includes:
First using 17- deshydroxy prednisone acetate as raw material, it is dissolved in the first organic solvent, with oxidant oxygen under acid catalysis
Change 16,17 double bonds, oxide: 16a- hydroxacetic acid prednisone is made；
Above-mentioned obtained 16a- hydroxacetic acid prednisone is dissolved in the second organic solvent again, acetone is added, acid catalysis is anti-
The protection that deserved 16,17 hydroxyls are protected by acetone；
Then protection obtained above is dissolved in third organic solvent, it is hydroxyl that reducing agent, which is added, and restores 11 ketone, and
Aqueous acid is directly added into after reduction reaction as acid catalyst, the acetone protection of 16,17 hydroxyls is taken off in hydrolysis, is made
16a- hydroxacetic acid prednisolone.
2. the method according to claim 1, wherein the described method includes:
A, the preparation of oxide:
It is that 17- deshydroxy prednisone acetate is dissolved in the first organic solvent, acid catalyst, stirring, temperature control to 10~50 is added
DEG C, it in oxidant potassium permanganate aqueous solution is added dropwise in 1~1.5 hour, after dripping off, then reacts 1~2 hour, TLC control reaction is eventually
Point, after having reacted, vacuum distillation recovered solvent, residue is cooled to room temperature, and pure water elutriation is added, and oxide is made in filtering:
16a- hydroxacetic acid prednisone crude product；The crude product is recrystallized with alcohol water blend, obtains 16a- hydroxacetic acid prednisone；
B, the preparation of protection:
Above-mentioned oxide is dissolved in the second organic solvent, is stirred, acetone and acid catalyst is added, it is small to keep the temperature lower reaction 6~12
When, TLC confirms reaction end, after having reacted, suitable alkali neutralization acid is added, then the organic molten of recycling 90~95% is concentrated under reduced pressure
Then agent is cooled to room temperature, pure water elutriation, filtering is added, and filtrate is discharged into purification tank for liquid waste, and filter cake washing and drying obtains protection；
C, the preparation of 16a- hydroxacetic acid prednisolone:
Protection prepared by above-mentioned B is dissolved in third organic solvent, stirs, is slowly added in 1~1.5 hour under heat preservation
Reducing agent, the reaction was continued 3~4 hours after adding, and TLC confirms reaction end, after having reacted, slowly drips in 0.5~1.0 hour
The aqueous acid for adding 5~10% after adding, continues hydrolysis 3~4 hours, and TLC confirms hydrolysis terminal, after having reacted,
The organic solvent of recycling 90~95% is concentrated under reduced pressure, is then cooled to room temperature, pure water elutriation, filtering is added, filtrate is discharged into waste water
Processing pond, filter cake washing and drying obtain 16a- hydroxacetic acid prednisolone.
3. according to the method described in claim 2, it is characterized in that, oxide prepares first organic solvent in the A
It is one or both of acetone, toluene, chloroform, ethyl acetate, THF, DME；Oxidant potassium permanganate concentration is 1~10%；
Acid catalyst is one of hydrochloric acid, sulfuric acid, phosphoric acid, p-methyl benzenesulfonic acid, acetic acid and formic acid；Weight proportion between reactant is,
Starting material: oxidant: acid catalyst=1g:0.2~0.8g:0.05~0.25g, the proportion between reactant and solvent are to rise
Beginning raw material: the first organic solvent=1g:10~30ml.
4. according to the method described in claim 3, it is characterized in that, oxide prepares first organic solvent in the A
It is acetone；Oxidant concentration is 3~5%；Acid catalyst is formic acid；Oxidizing reaction temperature is 20~25 DEG C；Weight between reactant
Amount proportion is starting material: oxidant: acid catalyst=1g:0.45g:0.1g, the proportion between reactant and solvent are to originate
Raw material: the first organic solvent=1g:20ml.
5. according to the method described in claim 2, it is characterized in that, protection prepares second organic solvent in the B
It is one or both of acetone, toluene, chloroform, ethyl acetate, THF, DME；Acid catalyst be hydrochloric acid, sulfuric acid, phosphoric acid, to first
One of benzene sulfonic acid, acid or glacial acetic acid；Protecting reaction temperature is 10~60 DEG C；Weight proportion between reactant is oxide:
Acetone: acid catalyst=1g:0.4~1.2g:0.01~0.20g, the proportion between reactant and solvent are oxides: second has
Solvent=1g:2~10ml.
6. according to the method described in claim 5, it is characterized in that, protection prepares second organic solvent in the B
It is acetone；Acid catalyst is p-methyl benzenesulfonic acid；Protecting reaction temperature is 25~30 DEG C；Weight proportion between reactant is to aoxidize
Object: acetone: acid catalyst=1g:0.6g:0.05g, the proportion between reactant and solvent are oxides: the second organic solvent=
1g:5ml.
7. according to the method described in claim 2, it is characterized in that, in the C 16a- hydroxacetic acid prednisolone preparation in institute
Stating third organic solvent is toluene, methylene chloride, acetone, chloroform, THF, DME, dioxane or C4 and following low-carbon alcohols；Also
Former agent is one of sodium borohydride, potassium borohydride, Lithium Aluminium Hydride；Reduction reaction temperature is 10~60 DEG C；The acid of hydrolysis
Acid in water is one of hydrochloric acid, sulfuric acid, phosphoric acid, p-methyl benzenesulfonic acid, acid or glacial acetic acid；Hydrolysising reacting temperature is 10~60
℃；Weight proportion between reduction reaction reactant is protection: reducing agent=1g:0.06~0.20g；Hydrolysis reactant
Between weight proportion be protection: acid catalyst=1g:0.20~0.40g；Proportion between reactant and solvent is protection:
Third organic solvent=1g:5~15ml.
8. the method according to the description of claim 7 is characterized in that in the C 16a- hydroxacetic acid prednisolone preparation in institute
Stating third organic solvent is alcohol；Reducing agent is sodium borohydride or potassium borohydride；Reduction reaction temperature is 20~25 DEG C；Hydrolysis is anti-
The acid answered is hydrochloric acid；Hydrolysising reacting temperature is 40~45 DEG C；Weight proportion between reduction reaction reactant is protection: reduction
Agent=1g:0.08g；Weight proportion between hydrolysis reactant is protection: acid=1g:0.28g；Between reactant and solvent
Proportion be protection: third organic solvent=1g:10ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910050760.6A CN109575095A (en) | 2019-01-20 | 2019-01-20 | A kind of preparation method of 16a- hydroxacetic acid prednisolone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910050760.6A CN109575095A (en) | 2019-01-20 | 2019-01-20 | A kind of preparation method of 16a- hydroxacetic acid prednisolone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109575095A true CN109575095A (en) | 2019-04-05 |
Family
ID=65917110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910050760.6A Pending CN109575095A (en) | 2019-01-20 | 2019-01-20 | A kind of preparation method of 16a- hydroxacetic acid prednisolone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109575095A (en) |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101200485A (en) * | 2006-12-13 | 2008-06-18 | 天津天药药业股份有限公司 | Production technique of drug intermediates |
| CN101878221A (en) * | 2007-11-30 | 2010-11-03 | 辉瑞有限公司 | Novel glucocorticoid receptor agonists |
| CN102015750A (en) * | 2008-02-27 | 2011-04-13 | 阿斯利康(瑞典)有限公司 | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use |
| CN101279997B (en) * | 2008-05-29 | 2011-08-24 | 鲁南制药集团股份有限公司 | Novel preparation of budesonide |
| CN103694306A (en) * | 2014-01-07 | 2014-04-02 | 成都医路康医学技术服务有限公司 | Method for preparing R-isomer by using S-isomer of budesonide |
| CN104231031A (en) * | 2014-09-10 | 2014-12-24 | 江西赣亮医药原料有限公司 | Preparation method of triamcinolone acetonide |
| CN104447930A (en) * | 2014-09-19 | 2015-03-25 | 重庆邮电大学 | Preparation method of 16a,17a-dyhydroxyl-21-acetoxyl-1,4-pregnene diene-3,11,20-triketone |
| CN105061549A (en) * | 2015-08-20 | 2015-11-18 | 上海信谊百路达药业有限公司 | Budesonide preparing method |
| CN105622713A (en) * | 2014-10-27 | 2016-06-01 | 天津金耀集团有限公司 | New process for reducing steroid 11-ketone group |
| WO2016120891A1 (en) * | 2015-01-30 | 2016-08-04 | Coral Drugs Pvt. Ltd. | Novel process for preparation of glucocorticoid steroids |
| CN104262440B (en) * | 2014-09-10 | 2016-08-17 | 江西赣亮医药原料有限公司 | A kind of preparation method of 16-hydroxy prednisonlone |
| CN107488203A (en) * | 2017-08-30 | 2017-12-19 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a hydroxy prednisonlones |
| CN103936813B (en) * | 2014-04-29 | 2018-07-13 | 浙江仙居君业药业有限公司 | A kind of synthetic method of desonide |
| CN109232695A (en) * | 2018-11-13 | 2019-01-18 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a, 21- biacetyl oxygroup prednisolone |
| CN109232696A (en) * | 2018-11-13 | 2019-01-18 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a- hydroxy prednisonlone product |
-
2019
- 2019-01-20 CN CN201910050760.6A patent/CN109575095A/en active Pending
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101200485A (en) * | 2006-12-13 | 2008-06-18 | 天津天药药业股份有限公司 | Production technique of drug intermediates |
| CN101878221A (en) * | 2007-11-30 | 2010-11-03 | 辉瑞有限公司 | Novel glucocorticoid receptor agonists |
| CN102015750A (en) * | 2008-02-27 | 2011-04-13 | 阿斯利康(瑞典)有限公司 | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use |
| CN101279997B (en) * | 2008-05-29 | 2011-08-24 | 鲁南制药集团股份有限公司 | Novel preparation of budesonide |
| CN103694306A (en) * | 2014-01-07 | 2014-04-02 | 成都医路康医学技术服务有限公司 | Method for preparing R-isomer by using S-isomer of budesonide |
| CN103936813B (en) * | 2014-04-29 | 2018-07-13 | 浙江仙居君业药业有限公司 | A kind of synthetic method of desonide |
| CN104262440B (en) * | 2014-09-10 | 2016-08-17 | 江西赣亮医药原料有限公司 | A kind of preparation method of 16-hydroxy prednisonlone |
| CN104231031A (en) * | 2014-09-10 | 2014-12-24 | 江西赣亮医药原料有限公司 | Preparation method of triamcinolone acetonide |
| CN104447930A (en) * | 2014-09-19 | 2015-03-25 | 重庆邮电大学 | Preparation method of 16a,17a-dyhydroxyl-21-acetoxyl-1,4-pregnene diene-3,11,20-triketone |
| CN105622713A (en) * | 2014-10-27 | 2016-06-01 | 天津金耀集团有限公司 | New process for reducing steroid 11-ketone group |
| WO2016120891A1 (en) * | 2015-01-30 | 2016-08-04 | Coral Drugs Pvt. Ltd. | Novel process for preparation of glucocorticoid steroids |
| CN105061549A (en) * | 2015-08-20 | 2015-11-18 | 上海信谊百路达药业有限公司 | Budesonide preparing method |
| CN107488203A (en) * | 2017-08-30 | 2017-12-19 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a hydroxy prednisonlones |
| CN109232695A (en) * | 2018-11-13 | 2019-01-18 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a, 21- biacetyl oxygroup prednisolone |
| CN109232696A (en) * | 2018-11-13 | 2019-01-18 | 湖南科瑞生物制药股份有限公司 | A kind of preparation method of 16a- hydroxy prednisonlone product |
Non-Patent Citations (2)
| Title |
|---|
| ASHTON, MICHAEL J.等: "Anti-inflammatory 17b-Thioalkyl-16a,17a-ketal and -acetal Androstanes: A New Class of Airway Selective Steroids for the Treatment of Asthma", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
| 姚其正等主编: "《药物合成反应》", 30 September 2012 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107488203B (en) | A kind of preparation method of 16a- hydroxy prednisonlone | |
| CN109232696A (en) | A kind of preparation method of 16a- hydroxy prednisonlone product | |
| CN113354574B (en) | Synthesis method of sodium picosulfate | |
| CN109651474A (en) | A kind of new preparation method of 16a- hydroxy prednisonlone | |
| CN109232697A (en) | A method of preparing 16a- hydroxy prednisonlone product | |
| CN109232695A (en) | A kind of preparation method of 16a, 21- biacetyl oxygroup prednisolone | |
| CN109081861A (en) | A kind of preparation method of 16a- hydroxy prednisonlone | |
| CN109575097A (en) | A kind of new preparation method of 16a- hydroxy prednisonlone product | |
| CN109575095A (en) | A kind of preparation method of 16a- hydroxacetic acid prednisolone | |
| CN109734763A (en) | A kind of preparation method of 16a- hydroxacetic acid prednisolone product | |
| CN109180764A (en) | It is a kind of to prepare 16a, the method for 21- biacetyl oxygroup prednisolone product | |
| CN114621103B (en) | Preparation method of salbutamol sulfate | |
| CN105294798A (en) | Preparation method of 17beta-androst-4-ene-3-one-17-carboxylic acid | |
| CN117567540A (en) | Preparation method of dydrogesterone intermediate | |
| JP2518146B2 (en) | Method for selectively reducing bile acid having keto group at 7-position | |
| CN109081860A (en) | A kind of preparation method of 16a, 21- biacetyl oxygroup prednisolone product | |
| CN107312052A (en) | A kind of preparation method of Methyllprednisolone | |
| CN104945459B (en) | A kind of method preparing finasteride intermediate | |
| CN118598950B (en) | Fusarium (Fu) and its preparation method Process for the preparation of a vegetable | |
| CN110128246B (en) | A kind of preparation method of hydroxytyrosol | |
| CN109251230A (en) | It is a kind of to prepare 16a, the method for 21- biacetyl oxygroup prednisolone | |
| CN109265507A (en) | A method of preparing 16a- hydroxy prednisonlone | |
| PL118827B1 (en) | Method of manufacture of tricyclicdiketone | |
| CN107200763A (en) | A kind of method using chenodeoxycholic acid as Material synthesis lithocholic acid | |
| CN106831923A (en) | A kind of preparation method of chenodeoxycholic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190405 |
|
| RJ01 | Rejection of invention patent application after publication |